28-10-2021 дата публикации
Номер: US20210331170A1
Автор:
Ad Omer,
Boer Robert E.,
Dyer Matthew,
Huang Haidong,
Leamon John H.,
Lv Caixia,
Millham Michele,
Nani Roger,
Reed Brian,
Rothberg Jonathan M.,
Schultz Jonathan C.
Methods and devices for preparing target molecules (e.g., target nucleic acids or target proteins) from a biological sample are provided herein. In some embodiments, methods and devices involve sample lysis, sample fragmentation, enrichment of target molecule(s), and/or functionalization of target molecule(s). 2. The device of claim 1 , wherein the biological sample is a single cell claim 1 , mammalian cell tissue claim 1 , animal sample claim 1 , fungal sample claim 1 , plant sample claim 1 , blood sample claim 1 , saliva sample claim 1 , sputum sample claim 1 , fecal sample claim 1 , urine sample claim 1 , buccal swab sample claim 1 , amniotic sample claim 1 , seminal sample claim 1 , synovial sample claim 1 , spinal sample claim 1 , or pleural fluid sample.3. The device of claim 1 , wherein the one or more target molecules are nucleic acids or proteins.4. The device of claim 1 , wherein the one or more microfluidic channels are configured to contain and/or transport fluid(s) and/or reagent(s).5. The device of claim 1 , wherein the functionalization cartridge comprises a first chamber comprising reagents that covalently modify a moiety Mof the one or more target molecules claim 1 , or of one or more fragments thereof claim 1 , to a modified moiety M.6. The device of claim 5 , wherein the reagents are non-enzymatic.7. The device of claim 5 , wherein the covalent modification is regiospecific.8. The device of claim 1 , wherein the portion of the one or more target molecules claim 1 , or of the one or more fragments thereof claim 1 , is a C-terminal carboxylate group or a C-terminal amino group.9. The device of claim 5 , wherein the reagents comprise buffers claim 5 , salts claim 5 , organic compounds claim 5 , acids claim 5 , and/or bases.10. The device of claim 5 , wherein the portion of the one or more target molecules claim 5 , or of the one or more fragments thereof claim 5 , is a C-terminal amino group claim 5 , and the covalent modification is diazo transfer. ...
Подробнее